Association of CYP7A1 -278A>C polymorphism and the response of plasma triglyceride after dietary intervention in dyslipidemic patients

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 6, 2009, Pages 487-493

  Barcelos, A L V ^a   Chies, R ^a   Almeida, S E M ^b,e   Fiegenbaum, M ^c   Schweigert, I D ^d   Chula, F G L ^e   Rossetti, M L ^a,e   Silva, C M D ^a,e  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b UNIVERSIDADE FEEVALE   (Brazil)

^c Rede Metodista IPA   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e Fundacao Estadual de Producao e Pesquisa em Saude   (Brazil)

Author keywords

CYP7A1; Diet; Dyslipidemia; Polymorphisms; Southern Brazil

Indexed keywords

ALANINE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYSTEINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESTRICTION ENDONUCLEASE; RESTRICTION ENDONUCLEASE BSAI; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BODY MASS; BRAZIL; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DISEASE CLASSIFICATION; DYSLIPIDEMIA; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LABORATORY DIAGNOSIS; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 68149164915     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009000600003     Document Type: Article

References (27)

1. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-364.
2. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-374.
3. Katan MB, Beynen AC, de Vries JH, Nobels A. Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am J Epidemiol 1986; 123: 221-234.
4. Ye SQ, Kwiterovich PO Jr. Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr 2000; 72: 1275S-1284S.
5. Lenicek M, Komarek V, Zimolova M, Kovar J, Jirsa M, Lukas M, et al. CYP7A1 promoter polymorphism -203A>C affects bile salt synthesis rate in patients after ileal resection. J Lipid Res 2008; 49: 2664-2667.
6. Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM. Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res 1999; 40: 1883-1889.
7. Hegele RA, Wang J, Harris SB, Brunt JH, Young TK, Hanley AJ, et al. Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 2001; 154: 579-587.
8. Hubacek JA, Pitha J, Skodova Z, Poledne R, Lanska V, Waterworth DM, et al. Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study. Clin Biochem 2003; 36: 263-267.
9. Hofman MK, Weggemans RM, Zock PL, Schouten EG, Katan MB, Princen HM. CYP7A1 A-278C polymorphism affects the response of plasma lipids after dietary cholesterol or cafestol interventions in humans. J Nutr 2004; 134: 2200-2204.
10. Jiang ZY, Han TQ, Suo GJ, Feng DX, Chen S, Cai XX, et al. Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol 2004; 10: 1508-1512.
11. Hofman MK, Groenendijk M, Verkuijlen PJ, Jonkers IJ, Mohrschladt MF, Smelt AH, et al. Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals. Eur J Hum Genet 2004; 12: 935-941.
12. Kovar J, Suchanek P, Hubacek JA, Poledne R. The A-204C polymorphism in the cholesterol 7alpha-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet. Physiol Res 2004; 53: 565-568.
13. Hubacek JA, Bobkova D. Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering. Mol Diagn Ther 2006; 10: 93-100.
14. Hofman MK, Princen HM, Zwinderman AH, Jukema JW. Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events. Clin Sci 2005; 108: 539-545.
15. Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ. A promoter polymorphism in cholesterol 7alpha-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin. Atherosclerosis 2005; 180: 407-415.
16. Princen H, Post SM, Twisk J. Regulation of bile acid synthesis. Curr Pharm Design 1997; 3: 59-64.
17. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, et al. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 2002; 110: 109-117.
18. Santos RD. III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2001; 77 (Suppl 3): 1-48.
19. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III). JAMA 2001; 285: 2486-2497.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
21. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
22. Hagiwara T, Kono S, Yin G, Toyomura K, Nagano J, Mizoue T, et al. Genetic polymorphism in cytochrome P450 7A1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Res 2005; 65: 2979-2982.
23. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 1998; 101: 1283-1291.
24. Qiao Y, Liu R, Bai H, Liu Y, Li X, Tang CW, et al. [Association between cholesterol 7alpha-hydroxylase -204A/C gene polymorphism and endogenous hypertriglyceridemia in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007; 24: 432-436.
25. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry 1992; 31: 4737-4749.
26. Abrahamsson A, Krapivner S, Gustafsson U, Muhrbeck O, Eggertsen G, Johansson I, et al. Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration. Atherosclerosis 2005; 182: 37-45.
27. Cheema SK, Cikaluk D, Agellon LB. Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7 alpha-hydroxylase gene expression. J Lipid Res 1997; 38: 315-323.